Integrating traditional Chinese (herbal) medicines into risk based regulation - With focus on non-clinical requirements to demonstrate safety
Within the public health sector of Hong Kong (China), there is a consensus around the important role of traditional Chinese medicines. For Hong Kong (China) to play a bridging role to bring Chinese medicines to the global market requires a concerted effort from the government, academic institutes an...
Main Author: | Vivian S.W. Chan Fung |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | Journal of Traditional Chinese Medical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095754820300235 |
Similar Items
-
Internationalization of Traditional/Complementary Medicine products: market entry as medicine
by: Jiatong Li, et al.
Published: (2018-10-01) -
A Comparative Study for License Application Regulations on Proprietary Chinese Medicines in Hong Kong and Canada
by: Linda L. D. Zhong, et al.
Published: (2021-03-01) -
Comparative study on registration application of proprietary Chinese medicine in the Guangdong-Hong Kong-Macau Greater Bay Area of China
by: Zicheng Liu, et al.
Published: (2024-12-01) -
Placebo design in WHO-registered trials of Chinese herbal medicine need improvements
by: Xuan Zhang, et al.
Published: (2019-11-01) -
Traditional herbal medicine
by: A Ziai
Published: (2002-05-01)